Korean drug pricing policy lacking efficiency and accessibility.

An opinion has been suggested that the drug pricing policy in Korea had kept relatively underestimating its economic efficiency and accessability compared to other advanced countries. Accordingly, the positive list system for the drug prices to be determined in its economic value as a cost and benefit, could be a good alternative measure.

In the meeting of "A debate for the desirable drug pr...